Table 3 Univariate and multivariate analysis of risk factors for ocular tuberculosis among HIV/MDR-TB co-infected patients (n=47)
Factors | Risk ratio | 95% Confidence intervals (CI) | p | Adjusted risk ratio | 95% CI | p | |
|---|---|---|---|---|---|---|---|
Sex | Male | 1 | |||||
Female | 0.17 | 0.02- 1.51 | 0.11 | ||||
Age, years | >40 | 1 | 1 | ||||
≤39 | 4.80 | 0.85-26.95 | 0.07 | 6.38 | 1.05-38.80 | 0.04 | |
Nadir CD4-count | ≤200 | 1 | |||||
>200 | 0.65 | 0.13-3.21 | 0.60 | ||||
CD4-count at evaluation | ≤200 | 1 | 1 | ||||
>200 | 0.59 | 0.10-3.35 | 0.55 | 0.21 | 0.18-2.52 | 0.21 | |
HIV viral load at evaluation | undetectable | 1 | |||||
detectable | 1.18 | 0.20-6.75 | 0.85 | ||||
Tuberculosis site | pulmonary | 1 | 1 | ||||
extrapulmonary | 11.62 | 1.96-68.87 | 0.007 | 13.65 | 2.37-78.53 | 0.003 | |
Time on MDR-TB treatment (months) | >6 | 1 | 1 | ||||
≤6 | 0.53 | 0.09-2.99 | 0.47 | 0.39 | 0.03-4.79 | 0.46 |